Intracameral bevacizumab for rubeotic glaucoma secondary to retinal vein occlusion

被引：6

作者：

Qureshi K. ^{[1
]}

Kashani S. ^{[2
]}

Kelly S.P. ^{[1
]}

机构：

[1] Bolton Hospitals NHS Trust, Bolton Eye Unit, Bolton NHS Trust, Farnworth, Bolton BL4 0JR, Minerva Road

[2] Moorfields Eye Hospital NHS Trust, London

来源：

International Ophthalmology | 2009年 / 29卷 / 6期

关键词：

Bevacizumab; Intracameral; Rubeotic glaucoma;

D O I：

10.1007/s10792-008-9262-y

中图分类号：

学科分类号：

摘要：

Two patients with ischaemic central retinal vein occlusion were treated with intracameral bevacizumab in order to affect the outcome of their disease. In addition, both patients underwent episodes of cycloablative and pan-retinal laser treatment. The patients were followed for more than 6 months and achieved some stability with a combination of these modalities. © 2008 Springer Science+Business Media B.V.

引用

页码：537 / 539

页数：2

共 6 条

[1]

Meyer C.H., Mennel S., Eter N., Incidence of endophthalmitis after intravitreal Avastin injection with and without postoperative topical antibiotic application, Ophthalmologe, 104, 11, pp. 952-957, (2007)

[2]

Fung A.E., Rosenfeld P.J., Reichel E., The International Intravitreal Bevacizumab Safety Survey: Using the internet to assess drug safety worldwide, British Journal of Ophthalmology, 90, 11, pp. 1344-1349, (2006)

[3]

Grisanti S., Biester S., Peters S., Tatar O., Ziemssen F., Bartz-Schmidt K.U., Intracameral Bevacizumab for Iris Rubeosis, American Journal of Ophthalmology, 142, 1, pp. 158-160, (2006)

[4]

Raghuram A., Saravanan V.R., Narendran V., Intracameral injection of bevacizumab (Avastin) to treat anterior chamber neovascular membrane in a painful blind eye, Indian J Ophthalmol, 55, 6, pp. 460-462, (2007)

[5]

Yazdani S., Hendi K., Pakravan M., Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma, Journal of Glaucoma, 16, 5, pp. 437-439, (2007)

[6]

Chalam K.V., Gupta S.K., Grover S., Brar V.S., Agarwal S., Intracameral Avastin dramatically resolves iris neovascularization and reverses neovascular glaucoma, Eur J Ophthalmol, 18, 2, pp. 255-262, (2008)

← 1 →